Cargando…
Adjuvant effect of anti-4-1BB mAb administration in adoptive T cell therapy of cancer
Administration of anti-4-1BB mAb has been found to be a potent adjuvant when combined with other therapeutic approaches, e.g. chemotherapy, cytokine therapies, anti-OX40 therapy, and peptide or DC vaccines. However, the adjuvant effect of anti-4-1BB mAb administration in adoptive T cell therapy of c...
Autores principales: | Li, Qiao, Iuchi, Takekazu, Jure-Kunkel, Maria N., Chang, Alfred E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2096735/ https://www.ncbi.nlm.nih.gov/pubmed/18071585 |
Ejemplares similares
-
State of the art in anti-cancer mAbs
por: Chiavenna, S. M., et al.
Publicado: (2017) -
SEPPA-mAb: spatial epitope prediction of protein antigens for mAbs
por: Qiu, Tianyi, et al.
Publicado: (2023) -
Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
por: Fusco, Marnie L., et al.
Publicado: (2015) -
The Different Colors of mAbs in Solution
por: Ambrogelly, Alexandre
Publicado: (2021) -
Treatment of Marmoset Intracerebral Hemorrhage with Humanized Anti-HMGB1 mAb
por: Wang, Dengli, et al.
Publicado: (2022)